![](/images/byd/57.jpg)
![](/images/byd/171.jpg)
![](/images/byd/300.jpg)
![](/images/byd/13.jpg)
![](/images/byd/227.jpg)
![](/images/byd/267.jpg)
Novel Technique to Treat Common Femoral Artery …
Several methods have been proposed to treat these pseudoaneurysms. In this report, we present three cases of successful pseudoaneurysm closure using a novel method of retrograde pseudoaneurysm access and thrombosis with Angio-Seal (St Jude Medical, St Paul, MN) closure device. This technique appears safe, effective, and reduces patient …
![](/image/whatsappp.png)
![](/images/byd/79.jpg)
![](/images/byd/228.jpg)
![](/images/byd/283.jpg)
Vascular Closure Device Failure: Frequency and …
Angio-Seal (St. Jude Medical, Inc, St. Paul, Minn) and the Perclose (Abbott Vascular, Santa Clara, Calif) devices remain the most popular VCDs. These devices have the potential to reduce the time to hemostasis, facilitate early patient mobi-lization, decrease hospital length of stay, and improve patient satisfaction.1–6 Clinical Perspective ...
![](/image/whatsappp.png)
![](/images/byd/73.jpg)
![](/images/byd/185.jpg)
![](/images/byd/322.jpg)
The efficacy and safety of closure of brachial access using the
Purpose: This study retrospectively evaluated the efficacy and safety of the 6F Angio-Seal (St. Jude Medical, St. Paul, Minn) as a closure device for transbrachial artery access for endovascular procedures in diabetic patients with critical limb ischemia. Methods: From January 2005 and September 2007, 1887 diabetic patients underwent interventional …
![](/image/whatsappp.png)
![](/images/byd/70.jpg)
![](/images/byd/178.jpg)
![](/images/byd/262.jpg)
Access site management with vascular closure devices
The Angio-Seal (St Jude Medical) received its initial approval from the Food and Drug Administration (FDA) in 1996. With more than 7 million devices distributed worldwide since its introduction, Angio-Seal is one of the most widely used arterial closure devices. This device went through multiple revisions, and the current one is very user …
![](/image/whatsappp.png)
![](/images/byd/70.jpg)
![](/images/byd/140.jpg)
![](/images/byd/325.jpg)
Device Update I: The Angio-Seal Device: A Current State …
The Angio-Seal STS Plus Platform (St. Jude Medical/Daig, Minnetonka, MN) plays a significant role in this growing trend, enabling earlier mobility and discharge of patients for efficient use of hospital staff and resources. With the healthcare industry's increasing shortage of qualified professionals and growing financial restrictions, these ...
![](/image/whatsappp.png)
![](/images/byd/95.jpg)
![](/images/byd/167.jpg)
![](/images/byd/339.jpg)
Vascular Closure Devices: A Comparative Overview
Deployment of Angio-Seal (images provided courtesy of St. Jude Medical). (A) The Angio-Seal sheath is placed within the vessel via the existing guide wire. It is advanced until blood flows out through the exit hole in the dilator as shown. It is then withdrawn until blood flow ceases and is advanced until the blood flow restarts.
![](/image/whatsappp.png)
![](/images/byd/112.jpg)
![](/images/byd/203.jpg)
![](/images/byd/334.jpg)
Iatrogenic subclavian artery puncture repair with Angio-Seal …
A central venous catheter (CVC) is used during high-risk operations to prevent hypovolemic shock. Whereas arterial puncture during CVC insertion is quite frequent (2.9%), arterial cannulation is a less common complication (0.2%) [].We describe the successful removal of a CVC, inadvertently placed in the subclavian artery, with a …
![](/image/whatsappp.png)
![](/images/byd/57.jpg)
![](/images/byd/148.jpg)
![](/images/byd/324.jpg)
![](/images/byd/81.jpg)
![](/images/byd/170.jpg)
![](/images/byd/315.jpg)
![](/images/byd/107.jpg)
![](/images/byd/145.jpg)
![](/images/byd/356.jpg)
Angio-Seal™ Evolution™ versus Manual Compression for …
Our institution has selectively used the Angio-Seal™ STS Plus (St. Jude Medical, Minnetonka, MN, USA) in neurovascular diagnostic angiography and intervention for about 2 years, finding effects similar to those of previous studies. Recently, our institution has newly introduced the Angio-Seal™ Evolution™ (St. Jude Medical, Minnetonka, MN ...
![](/image/whatsappp.png)
![](/images/byd/72.jpg)
![](/images/byd/212.jpg)
![](/images/byd/276.jpg)
![](/images/byd/8.jpg)
![](/images/byd/167.jpg)
![](/images/byd/355.jpg)
![](/images/byd/60.jpg)
![](/images/byd/137.jpg)
![](/images/byd/338.jpg)
![](/images/byd/76.jpg)
![](/images/byd/224.jpg)
![](/images/byd/268.jpg)
Gluteale Ischämie als Folge eines akuten Verschlusses der A …
Die Punktionsstelle in der linken Leiste wurde mittels 6F Angio-Seal™ (St. Jude Medical, Saint Paul, MN, USA) versorgt. ... Nach Verwendung des kollagenbasierten Verschlusssystems Angio-Seal™ treten laut einer Metanalyse von Das et al. in 1,2 % Hämatome, in 0,8 % Blutungen, in 0,4 % Pseudoaneurysmen und in 0,2 % der Fälle …
![](/image/whatsappp.png)
![](/images/byd/111.jpg)
![](/images/byd/215.jpg)
![](/images/byd/322.jpg)
![](/images/byd/43.jpg)
![](/images/byd/236.jpg)
![](/images/byd/345.jpg)
Vascular Closure Device Failure: Frequency and Implications
Angio-Seal (St. Jude Medical, Inc, St. Paul, Minn) and the Perclose (Abbott Vascular, Santa Clara, Calif) devices remain the most popular VCDs. These devices have the potential to reduce the time to hemostasis, facilitate early patient mobilization, decrease hospital length of stay, and improve patient satisfaction. 1–6
![](/image/whatsappp.png)
![](/images/byd/117.jpg)
![](/images/byd/227.jpg)
![](/images/byd/258.jpg)
![](/images/byd/88.jpg)
![](/images/byd/135.jpg)
![](/images/byd/277.jpg)
![](/images/byd/57.jpg)
![](/images/byd/190.jpg)
![](/images/byd/339.jpg)
Histologic and duplex comparison of the perclose and angio-seal …
In each dog, one of two devices (Perclose, Abbot Laboratories, Abbott Park, IL or Angio-Seal, St. Jude Medical, St. Paul, MN) was randomly deployed into one of the two femoral arteries. The other device was deployed on the opposite side. Duplex sonography was repeated immediately after deployment and 28 days later to measure changes in vessel ...
![](/image/whatsappp.png)
![](/images/byd/28.jpg)
![](/images/byd/207.jpg)
![](/images/byd/261.jpg)
StarClose Vascular Closure Device: Safety and Efficacy of …
MATERIALS AND METHODS: We performed a retrospective review of all patients who underwent neurointerventional procedures at our institution between January 1, 2006 and December 31, 2008. We evaluated the safety and efficacy of the StarClose device in patients undergoing first and repeat procedures. Groin complications were classified …
![](/image/whatsappp.png)
![](/images/byd/108.jpg)
![](/images/byd/194.jpg)
![](/images/byd/243.jpg)
ANGIO-SEAL® VIP VASCULAR CLOSURE DEVICE | TMCI
The Angio-Seal Vascular Closure Device product family, including the VIP and Evolution platforms, is indicated for use in closing and reducing time to hemostasis of the femoral arterial puncture site in patients who have undergone diagnostic angiography procedures or interventional procedures using an 8 French or smaller procedural sheath for ...
![](/image/whatsappp.png)
![](/images/byd/43.jpg)
![](/images/byd/153.jpg)
![](/images/byd/280.jpg)
StarClose Vascular Closure Device: Safety and Efficacy of …
Several percutaneous closure devices are available and rely on either 1) passive closure with enhanced manual compression by using external patches with prothrombotic coatings (Syvtek Patch; Marine Polymer Technologies, Danvers, Massachusetts) or 2) active closure by using suture-mediated closure (Perclose; Abbott …
![](/image/whatsappp.png)
![](/images/byd/93.jpg)
![](/images/byd/170.jpg)
![](/images/byd/321.jpg)
The Angio-Seal Device
The Angio-Seal device can be deployed using a 6 or 8F closure system that permits closure of arteries up to 9F. The clinical effectiveness of closure devices should be considered in terms of their effect on clinical outcomes, time to ambulation, and patient satisfaction. The Angio-Seal closure device favorably affects all three of these areas.
![](/image/whatsappp.png)
![](/images/byd/44.jpg)
![](/images/byd/184.jpg)
![](/images/byd/342.jpg)
Access site management with vascular closure devices …
Angio-Seal VIP, Angio-Seal STS Plus St Jude Medical 6, 8 0.038 These are earlier versions of Angio-Seal family, which deliver collagen plugs to close the arteriotomy. Collagens are reabsorbed within 90 days. Device application allows for immediate repeat access. Angio-Seal Evolution St Jude Medical 4-8 0.038 This is most …
![](/image/whatsappp.png)
![](/images/byd/109.jpg)
![](/images/byd/190.jpg)
![](/images/byd/248.jpg)
Accelerated ambulation after vascular access closure device
The Angioseal® (St. Jude Medical, Saint Paul, Minnesota) closure device is a vascular plug that has been approved by the Food and Drug Administration (FDA) in order to seal the femoral artery arteriotomy site and to allow for an earlier ambulation time following cardiac catheterization. ... The Angio-Seal arterial closure device for early ...
![](/image/whatsappp.png)
![](/images/byd/86.jpg)
![](/images/byd/196.jpg)
![](/images/byd/303.jpg)
![](/images/byd/118.jpg)
![](/images/byd/133.jpg)
![](/images/byd/290.jpg)
![](/images/byd/65.jpg)
![](/images/byd/172.jpg)
![](/images/byd/244.jpg)
![](/images/byd/42.jpg)
![](/images/byd/168.jpg)
![](/images/byd/266.jpg)
Ultrasonographic features of vascular closure devices: initial …
Results: Initial ultrasonography revealed the attached VCD as the relevant unique structure with successful deployment and hemostasis. Follow-up ultrasonography demonstrated partial absorption of hemostatic materials in cases of Angio-Seal (n=3), FemoSeal (n=5), and ExoSeal (n=3), changes in the soft tissue surrounding the femoral …
![](/image/whatsappp.png)
![](/images/byd/52.jpg)
![](/images/byd/227.jpg)
![](/images/byd/316.jpg)
Vascular Closure Devices: The Second Decade
Instructions for Use Angio-Seal VIP; St. Jude Medical February 2006 ... Although the Angio-Seal and Perclose devices, the 2 VCDs with the longest period of commercial availability, have both undergone significant evolution and improvement (7), closure failures with these devices still occur. Moreover, the newest commercially …
![](/image/whatsappp.png)
![](/images/byd/108.jpg)
![](/images/byd/199.jpg)
![](/images/byd/342.jpg)
A systematic review of vascular closure devices for femoral …
Angio-Seal (St. Jude Medical, St. Paul, Minn; Fig 3) is a passive approximator that deploys a collagen plug over the arteriotomy site with the aid of an intraluminal anchor. After intraluminal placement is confirmed, an anchor abuts the wall and a collagen plug is deployed over the arteriotomy. The plug expands when it enters the …
![](/image/whatsappp.png)
![](/images/byd/98.jpg)
![](/images/byd/237.jpg)
![](/images/byd/298.jpg)
Terumo Completes Acquisition of Vascular Closure Business …
Terumo Completes Acquisition of Vascular Closure Business and Other Assets of Abbott and St. Jude Medical. ... Terumo has acquired the Angio-Seal™ and FemoSeal™ vascular closure product lines and Kalila Medical, Inc., a company developing next-generation access technologies, the first being the Vado™ Steerable Sheath, used …
![](/image/whatsappp.png)
![](/images/byd/100.jpg)
![](/images/byd/173.jpg)
![](/images/byd/299.jpg)
Arterielle Verschlusssysteme | Die Radiologie
Freisetzung des Angio-Seal®-Verschlusssystems. a Austausch der verwendeten Schleuse gegen die Angio-Seal®-Schleuse über Führungsdraht. Pulsatiler Blutfluss muss am Indikator auftreten. b Introducer entfernen und Angio-Seal® in Schleuse einführen, bis es mit einem hörbaren Klick einrastet. Nun die Verschlusskappe langsam …
![](/image/whatsappp.png)
![](/images/byd/105.jpg)
![](/images/byd/205.jpg)
![](/images/byd/306.jpg)
Comparison of Exo-Seal® and Angio-Seal® for arterial …
Angio-Seal ® (St. Jude Medical, St. Paul, Minn.) is a collagen-based plug system with a flat, absorbable rectangular anchor, an absorbable collagen plug, and an absorbable suture. Exo-Seal ® (Cordis, Warren, N.J.) is a closure device with a bioabsorbable polyglycolic acid (PGA) plug, which is administered to the extravascular …
![](/image/whatsappp.png)
![](/images/byd/109.jpg)
![](/images/byd/209.jpg)
![](/images/byd/242.jpg)
![](/images/byd/63.jpg)
![](/images/byd/146.jpg)
![](/images/byd/351.jpg)
Arterial Closure Device Insertion: Background, Indications
Active closure devices include collagen-based devices such as Angio-Seal (St Jude Medical, St Paul, MN) or MANTA (Teleflex, Morrisville, NC), suture-based devices such as Perclose ProGlide or Starclose (Abbott Vascular, Redwood City, CA), and polyethylene glycol (PEG)–based devices such as Mynx Cadence (AccessClosure, …
![](/image/whatsappp.png)
![](/images/byd/104.jpg)
![](/images/byd/210.jpg)
![](/images/byd/296.jpg)
Experiencia acumulada en el uso de Angio-Seal
El dispositivo de cierre de punción femoral Angio-Seal™ (St. Jude Medical, St. Paul, Minnesota) es actualmente el más utilizado en nuestro medio para el cierre de las punciones femorales en los que se utilizan introductores hasta 8F, con excelentes resultados, sin apenas complicaciones, y que permite una movilización precoz del …
![](/image/whatsappp.png)
![](/images/byd/6.jpg)
![](/images/byd/178.jpg)
![](/images/byd/286.jpg)
INSTRUCTIONS FOR USE
The Angio-Seal™ device was evaluated in a non-randomized clinical trial involving 306 patients in whom the access sites were closed with the device following diagnostic angiography (n=97) or percutaneous coronary intervention (n=209) procedures. Table 1 reports the adverse events as a percentage of patients who received the Angio-Seal …
![](/image/whatsappp.png)